Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Clin Cancer Res. 2010 Feb 16;16(5):1642–1651. doi: 10.1158/1078-0432.CCR-09-2701

Figure 1.

Figure 1

T cell responses to 13 immunogenic HY peptides in FM patients, MM patients, normal females (NF) and normal males (NM).

13 HY peptides are listed in the same order on the X axis in patient and control groups. The Y axis represents the number of spots/200,000 cells in ELISPOT assay for each peptide after subtraction of values for negative control peptides (HIV or HCV). Values >20 spots/200,000 cells are considered positive. Open symbols represent the previously known HLA A*0201 restricted HY.